NPPA revises 6 pack prices

NEW DELHI, DEC 29: Prices of six new pharmaceutical formulation packs belonging to Cadila group have been fixed for the first time by the National Pharmaceutical Pricing Authority NPPA on Tuesday. Besides, non-ceiling prices of another 11 formulation packs have been revised, according to a release by the Ministry of Chemicals and Fertilisers.

In this round of price revision/fixation, as many as nine drugs of Cadila Healthcare/Cadila Pharma companies are involved. The other companies whose formulation prices have been revised/fixed are Wyeth Lederle, Core Healthcare, Hoechst Marion Roussel, Merind, Ranbaxy and Morpen Lab.

Of the total of 17 formulation packs for which prices have been revised/fixed, prices of two packs have been revised downwards. Prices of the remaining formulations have been revised upwards. Manufacturers have been given a fortnight8217;s time to adhere to the revised/fixed price structure from the date of the receipt of the NPPA order, the release adds.